Suppr超能文献

朊病毒蛋白(PrP)中中央赖氨酸簇的电荷中和促进重组PrP淀粉样蛋白的PrP(Sc)样折叠。

Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.

作者信息

Groveman Bradley R, Kraus Allison, Raymond Lynne D, Dolan Michael A, Anson Kelsie J, Dorward David W, Caughey Byron

机构信息

From the Laboratory of Persistent Viral Diseases and.

the Computational Biology Section, Bioinformatics and Computational Biosciences Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

J Biol Chem. 2015 Jan 9;290(2):1119-28. doi: 10.1074/jbc.M114.619627. Epub 2014 Nov 21.

Abstract

The structure of the infectious form of prion protein, PrP(Sc), remains unclear. Most pure recombinant prion protein (PrP) amyloids generated in vitro are not infectious and lack the extent of the protease-resistant core and solvent exclusion of infectious PrP(Sc), especially within residues ∼90-160. Polyanionic cofactors can enhance infectivity and PrP(Sc)-like characteristics of such fibrils, but the mechanism of this enhancement is unknown. In considering structural models of PrP(Sc) multimers, we identified an obstacle to tight packing that might be overcome with polyanionic cofactors, namely, electrostatic repulsion between four closely spaced cationic lysines within a central lysine cluster of residues 101-110. For example, in our parallel in-register intermolecular β-sheet model of PrP(Sc), not only would these lysines be clustered within the 101-110 region of the primary sequence, but they would have intermolecular spacings of only ∼4.8 Å between stacked β-strands. We have now performed molecular dynamics simulations predicting that neutralization of the charges on these lysine residues would allow more stable parallel in-register packing in this region. We also show empirically that substitution of these clustered lysine residues with alanines or asparagines results in recombinant PrP amyloid fibrils with extended proteinase-K resistant β-sheet cores and infrared spectra that are more reminiscent of bona fide PrP(Sc). These findings indicate that charge neutralization at the central lysine cluster is critical for the folding and tight packing of N-proximal residues within PrP amyloid fibrils. This charge neutralization may be a key aspect of the mechanism by which anionic cofactors promote PrP(Sc) formation.

摘要

朊病毒蛋白的感染性形式PrP(Sc)的结构仍不清楚。大多数在体外产生的纯重组朊病毒蛋白(PrP)淀粉样蛋白没有传染性,并且缺乏感染性PrP(Sc)的蛋白酶抗性核心程度和溶剂排斥,特别是在约90-160位残基范围内。聚阴离子辅因子可以增强此类纤维的感染性和PrP(Sc)样特征,但这种增强的机制尚不清楚。在考虑PrP(Sc)多聚体的结构模型时,我们发现了一个紧密堆积的障碍,而聚阴离子辅因子可能会克服这一障碍,即101-110位残基中央赖氨酸簇内四个紧密间隔的阳离子赖氨酸之间的静电排斥。例如,在我们的PrP(Sc)平行同序分子间β-折叠模型中,这些赖氨酸不仅会聚集在一级序列的101-110区域内,而且在堆叠的β-链之间的分子间距仅约为4.8 Å。我们现在进行了分子动力学模拟,预测这些赖氨酸残基上的电荷中和将使该区域内更稳定的平行同序堆积成为可能。我们还通过实验表明,用丙氨酸或天冬酰胺取代这些聚集的赖氨酸残基会导致重组PrP淀粉样纤维具有延长的蛋白酶K抗性β-折叠核心和更类似于真正PrP(Sc)的红外光谱。这些发现表明,中央赖氨酸簇处的电荷中和对于PrP淀粉样纤维内N端残基的折叠和紧密堆积至关重要。这种电荷中和可能是阴离子辅因子促进PrP(Sc)形成机制的一个关键方面。

相似文献

3
Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates.
PLoS Pathog. 2017 Sep 14;13(9):e1006623. doi: 10.1371/journal.ppat.1006623. eCollection 2017 Sep.
4
Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.
PLoS Pathog. 2011 Dec;7(12):e1002419. doi: 10.1371/journal.ppat.1002419. Epub 2011 Dec 1.
5
Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region.
J Biol Chem. 2014 Jan 31;289(5):2643-50. doi: 10.1074/jbc.M113.520718. Epub 2013 Dec 12.
6
Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):18946-51. doi: 10.1073/pnas.0706522104. Epub 2007 Nov 19.
7
Amyloid fibrils from the N-terminal prion protein fragment are infectious.
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13851-13856. doi: 10.1073/pnas.1610716113. Epub 2016 Nov 14.
8
In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm.
FEBS Lett. 2006 Jul 24;580(17):4231-5. doi: 10.1016/j.febslet.2006.06.074. Epub 2006 Jul 5.
10
A new mechanism for transmissible prion diseases.
J Neurosci. 2012 May 23;32(21):7345-55. doi: 10.1523/JNEUROSCI.6351-11.2012.

引用本文的文献

1
RNA as a component of scrapie fibrils.
Sci Rep. 2024 Feb 29;14(1):5011. doi: 10.1038/s41598-024-55278-0.
2
Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases.
Acta Neuropathol. 2024 Jan 17;147(1):17. doi: 10.1007/s00401-023-02661-2.
3
Cryo-EM of prion strains from the same genotype of host identifies conformational determinants.
PLoS Pathog. 2022 Nov 7;18(11):e1010947. doi: 10.1371/journal.ppat.1010947. eCollection 2022 Nov.
4
Seed amplification and RT-QuIC assays to investigate protein seed structures and strains.
Cell Tissue Res. 2023 Apr;392(1):323-335. doi: 10.1007/s00441-022-03595-z. Epub 2022 Mar 8.
5
Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies.
Front Bioeng Biotechnol. 2020 Oct 20;8:585896. doi: 10.3389/fbioe.2020.585896. eCollection 2020.
7
Isolation of infectious, non-fibrillar and oligomeric prions from a genetic prion disease.
Brain. 2020 May 1;143(5):1512-1524. doi: 10.1093/brain/awaa078.
8
Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons.
Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23029-23039. doi: 10.1073/pnas.1909322116. Epub 2019 Oct 22.
10
Characterization of mutations in (prion) gene and their possible roles in neurodegenerative diseases.
Neuropsychiatr Dis Treat. 2018 Aug 14;14:2067-2085. doi: 10.2147/NDT.S165445. eCollection 2018.

本文引用的文献

1
Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.
J Biol Chem. 2014 Aug 29;289(35):24129-42. doi: 10.1074/jbc.M114.578344. Epub 2014 Jul 15.
2
Heparin binding confers prion stability and impairs its aggregation.
FASEB J. 2014 Jun;28(6):2667-76. doi: 10.1096/fj.13-246777. Epub 2014 Mar 19.
3
Cofactor molecules induce structural transformation during infectious prion formation.
Structure. 2013 Nov 5;21(11):2061-8. doi: 10.1016/j.str.2013.08.025. Epub 2013 Oct 10.
4
Prions and the potential transmissibility of protein misfolding diseases.
Annu Rev Microbiol. 2013;67:543-64. doi: 10.1146/annurev-micro-092412-155735. Epub 2013 Jun 28.
6
Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions.
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):E1938-46. doi: 10.1073/pnas.1206999109. Epub 2012 Jun 18.
8
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids.
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8546-51. doi: 10.1073/pnas.1204498109. Epub 2012 May 14.
9
The amyloid state of proteins in human diseases.
Cell. 2012 Mar 16;148(6):1188-203. doi: 10.1016/j.cell.2012.02.022.
10
Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange.
Nat Struct Mol Biol. 2011 Apr;18(4):504-6. doi: 10.1038/nsmb.2035. Epub 2011 Mar 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验